朱华，男，博士、副研究员。主要从事新型放射性药物研制及临床转化，推动10余种核素探针用于临床。中国核学会放射性药物分会(首届)秘书长 (常务理事、联合创始人)、核化学与放射化学分会第九届理事，中华医学会核医学分会第十届青委。近5年，发表通讯/第一作者SCI论文21篇，申请国家发明专利十余项(4项授权)。获2项国家自然科学基金(1项在研)，2项国家重点研发计划(项目骨干)，北京市自然科学基金(优秀成果)，北京市“科技新星”、优秀人才培养“青年拔尖”，等多个项目支持，在研经费300 余万。
发表论文情况
近3年代表性论文(10 篇)：( ?代表共同第一作者，*代表通讯作者)
1. Hua Zhu, Liu Fei, Yan Zhang, Jianhua Yang, Xiaoxia Xu, Xiaoyi Guo, Teli Liu, Nan Li, Lin Zhu, Hank F. Kung*, Zhi Yang*. [18F](2S,4R)-4-Fluoroglutamine as a PET indicator for bone marrow metabolism dysfunctional: From animal experiments to clinical application. Molecular Imaging and Biology. 2019. DOI: 10.1007/s11307-019-01319-4. (Q1, SCI 3.626)
2. Teli Liu?, Chen Liu?, Xiaoxia Xu, Fei Liu, Xiaoyi Guo, Nan Li, Xuejuan Wang, Jianhua Yang, Xing Yang, Hua Zhu*, Zhi Yang*. Preclinical evaluation and primary clinical study of Al18F-PSMA-BCH in PET imaging of prostate cancer. Journal of Nuclear Medicine, 2019, doi:10.2967/jnumed.118.221671. (Q1, SCI 7.439)
3. Fei Liu?, Xiaoxia Xu?, Hua Zhu?, Yan Zhang, Jianhua Yang, Lifang Zhang, Nan Li, Lin Zhu, Hank F. Kung*, Zhi Yang*. PET Imaging of 18F-(2S,4R)4-fluoroglutamine Accumulation in Breast Cancer: from Xenografts to Patients. Molecular Pharmaceutics. 2018, 15 (8), pp 3448-3455. (SCI IF 4.556 Q1 )
4. Feng Wang, Teli Liu, Liqiang Li, Xiaoyi Guo, Dongban Duan, Zhibo Liu, Hua Zhu*, Zhi Yang. Production, Quality Control of next-generation PET radioisotope Iodine-124 and its Thyroid Imaging. J Radio. Nucl. Chem. 2018, 318: 1999-2006. (SCI IF 1.2, Q2)
5. Xiaoyi Guo?, Hua Zhu?, Nina Zhou, Zuhua Chen, Teli Liu, Fei Liu, Xiaoxia Xu, Hongjun Jin, Lin Shen, Jing Gao*, and Zhi Yang*.Non-invasive Detection of HER2 Expression in Gastric Cancer by 64Cu-NOTA-Trastuzumab in PDX Mouse Model and in Patients. Molecular Pharmaceutics. 2018, 15 (11), 5174–5182 (SCI IF 4.556 Q1 )
6. C Liu, TL Liu, N Zhang, YQ Liu, N Li, P Du, Y Yang, M Liu, K Gong, X Yang, H Zhu*, K Yan, Z Yang*. 68Ga-PSMA-617 PET/CT: a promising new technique for predicting risk stratification and metastatic risk of prostate cancer patients. European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45(11): 1852–1861. (SCI IF 7.7, Q1)
7. F Liu, TL Liu; XX Xu, XY Guo, N Li, CY Xiong, C Li, H Zhu*, Z Yang*. Design, Synthesis and Biological Evaluation of 68Ga-DOTA-PA1 for Lung Cancer: A Novel PET Tracer for Multiple Somatostatin Receptors Imaging. Molecular Pharmaceutics. 2018. 15, 619?628. (SCI IF 4.4).
8. Xie QH?, Zhu H?, Wang F, Meng XX, Ren QS, Xia CQ *, Yang Z*.Establishing Reliable 64Cu Production Process: From Target Plating to Molecular Specific Tumor Micro-PET Imaging. Molecules 2017, 22, 641. (SCI IF 2.86)
9. Hua Zhu?, Chuanke Zhao?, Fei Liu, Lixin Wang, Junnan Feng, Chengchao Shou*, Zhi Yang*. 125I-F56 peptide as radio-analysis agent targeting VEGFR1 in mice xenografted with human gastric tumor. ACS Med. Chem. Lett. 2017, 8, 266-269. (SCI IF 3.74) (**)
10. Wu Y?, Zhu H?, Zhang B, Liu F, Chen J, Wang Y, Wang Y, Zhang Z, Wu L, Si L, Xu H, Yao T, Xiao S, Xia Q, Zhang L, Yang Z*, Zhou D*. Synthesis of Site-Specific Radiolabeled Antibodies for Radioimmunotherapy via Genetic Code Expansion. Bioconjug Chem. 2016, 27(10), 2460–2468. (? Equal Contribution) (IF 4.5, **)